Ausgabe 1/2020
Inhalt (26 Artikel)
Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort
Angela S. Cheng, Samuel C. Y. Leung, Dongxia Gao, Samantha Burugu, Meenakshi Anurag, Matthew J. Ellis, Torsten O. Nielsen
Residual cancer burden index and tumor-infiltrating lymphocyte subtypes in triple-negative breast cancer after neoadjuvant chemotherapy
Clémence Pinard, Marc Debled, Houda Ben Rejeb, Valérie Velasco, Christine Tunon de Lara, Stéphanie Hoppe, Elodie Richard, Véronique Brouste, Hervé Bonnefoi, Gaëtan MacGrogan
High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer
Mikhail Gorbounov, Neil M. Carleton, Rebecca J. Asch-Kendrick, Lingling Xian, Lisa Rooper, Lionel Chia, Ashley Cimino-Mathews, Leslie Cope, Alan Meeker, Vered Stearns, Robert W. Veltri, Young Kyung Bae, Linda M. S. Resar
The intra-tumoural stroma in patients with breast cancer increases with age
Kiki M. H. Vangangelt, Claire J. H. Kramer, Esther Bastiaannet, Hein Putter, Danielle Cohen, Gabi W. van Pelt, Emad A. Rakha, Andrew R. Green, Rob A. E. M. Tollenaar, Wilma E. Mesker
COTI-2 reactivates mutant p53 and inhibits growth of triple-negative breast cancer cells
Naoise C. Synnott, David O’Connell, John Crown, Michael J. Duffy
Prevalence and scope of advanced practice provider oncology care among Medicare beneficiaries with breast cancer
Tina W. F. Yen, Purushottam W. Laud, Emily L. McGinley, Liliana E. Pezzin, Ann B. Nattinger
Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy
Suzanne E. Wardell, Alexander P. Yllanes, Christina A. Chao, Yeeun Bae, Kaitlyn J. Andreano, Taylor K. Desautels, Kendall A. Heetderks, Jeremy T. Blitzer, John D. Norris, Donald P. McDonnell
The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer
Abrar I. Aljohani, Michael S. Toss, Sasagu Kurozumi, Chitra Joseph, Mohammed A. Aleskandarany, Islam M. Miligy, Rokaya El Ansari, Nigel P. Mongan, Ian O. Ellis, Andrew R. Green, Emad A. Rakha
Patient-reported outcomes and objective assessments with arm measurement and bioimpedance analysis for lymphedema among breast cancer survivors
Mitsuo Terada, Akiyo Yoshimura, Masataka Sawaki, Masaya Hattori, Gondo Naomi, Haruru Kotani, Yayoi Adachi, Madoka Iwase, Ayumi Kataoka, Kayoko Sugino, Makiko Mori, Nanae Horisawa, Yuri Ozaki, Hiroji Iwata
Pathological complete response to neoadjuvant systemic therapy in 789 early and locally advanced breast cancer patients: The Royal Marsden experience
Nicolò Matteo Luca Battisti, Victoria True, Narda Chaabouni, Neha Chopra, Karla Lee, Scott Shepherd, Tal Shapira-Rotenberg, Rashi Joshi, Sophie McGrath, Alicia Okines, Marina Parton, Nicholas Turner, Kabir Mohammed, Mark Allen, Stephen Johnston, Alistair Ring
A phase II study of cabozantinib alone or in combination with trastuzumab in breast cancer patients with brain metastases
José Pablo Leone, Dan G. Duda, Jiani Hu, William T. Barry, Lorenzo Trippa, Elizabeth R. Gerstner, Rakesh K. Jain, Sally Tan, Elizabeth Lawler, Eric P. Winer, Nancy U. Lin, Sara M. Tolaney
Factors associated with endometrial pathology during tamoxifen therapy in women with breast cancer: a retrospective analysis of 821 biopsies
Jungeun Jeon, Sung Eun Kim, Dong-Yun Lee, DooSeok Choi
Correlation between patency and clinical improvement after lymphaticovenous anastomosis (LVA) in breast cancer-related lymphedema: 12-month follow-up
Joost A. G. N. Wolfs, Luuke G. E. H. de Joode, René R. W. J. van der Hulst, Shan S. Qiu
Long-term prognostic effect of hormone receptor subtype on breast cancer
Ki-Tae Hwang, Jongjin Kim, Jiwoong Jung, Byoung Hyuck Kim, Jeong Hwan Park, Sook Young Jeon, Kyu Ri Hwang, Eun Youn Roh, Jin Hyun Park, Su-jin Kim
Sixty spontaneous vertebral fractures after denosumab discontinuation in 15 women with early-stage breast cancer under aromatase inhibitors
Elena Gonzalez-Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, Khalil Zaman, Olivier Lamy
A pooled analysis of the cardiac events in the trastuzumab adjuvant trials
Evandro de Azambuja, Noam Ponde, Marion Procter, Priya Rastogi, Reena S. Cecchini, Matteo Lambertini, Karla Ballman, Alvaro Moreno Aspitia, Dimitrios Zardavas, Lise Roca, Richard D. Gelber, Martine Piccart-Gebhart, Thomas Suter
Effect of progressive resistance training on persistent pain after axillary dissection in breast cancer: a randomized controlled trial
Gunn Ammitzbøll, Kenneth Geving Andersen, Pernille Envold Bidstrup, Christoffer Johansen, Charlotte Lanng, Niels Kroman, Bo Zerahn, Ole Hyldegaard, Elisabeth Wreford Andersen, Susanne Oksbjerg Dalton
Bimodal age distribution at diagnosis in breast cancer persists across molecular and genomic classifications
Emma H. Allott, Yue Shan, Mengjie Chen, Xuezheng Sun, Susana Garcia-Recio, Erin L. Kirk, Andrew F. Olshan, Joseph Geradts, H. Shelton Earp, Lisa A. Carey, Charles M. Perou, Ruth M. Pfeiffer, William F. Anderson, Melissa A. Troester
Research-based PAM50 signature and long-term breast cancer survival
Minya Pu, Karen Messer, Sherri R. Davies, Tammi L. Vickery, Emily Pittman, Barbara A. Parker, Matthew J. Ellis, Shirley W. Flatt, Catherine R. Marinac, Sandahl H. Nelson, Elaine R. Mardis, John P. Pierce, Loki Natarajan
Racial differences in employment and cost-management behaviors in patients with metastatic breast cancer
Cleo A. Samuel, Jennifer C. Spencer, Donald L. Rosenstein, Katherine E. Reeder-Hayes, Michelle L. Manning, Jean B. Sellers, Stephanie B. Wheeler
Factors associated with endocrine therapy adherence among post-menopausal women treated for early-stage breast cancer in Ontario, Canada
Phillip S. Blanchette, Melody Lam, Lucie Richard, Britney Allen, Salimah Z. Shariff, Ted Vandenberg, Kathleen I. Pritchard, Kelvin K. W. Chan, Alexander V. Louie, Danielle Desautels, Jacques Raphael, Craig C. Earle
Distinct trajectories of fruits and vegetables, dietary fat, and alcohol intake following a breast cancer diagnosis: the Pathways Study
Zaixing Shi, Andrew Rundle, Jeanine M. Genkinger, Ying Kuen Cheung, Isaac J. Ergas, Janise M. Roh, Lawrence H. Kushi, Marilyn L. Kwan, Heather Greenlee
Optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibodies confirms its expression in normal and malignant breast tissues
John R. Hawse, Jodi M. Carter, Kirsten G. M. Aspros, Elizabeth S. Bruinsma, Justin W. Koepplin, Vivian Negron, Malayannan Subramaniam, James N. Ingle, Karen L. Rech, Matthew P. Goetz
Risk-reducing mastectomy in BRCA carriers: survival is not the issue
P. Neven, K. Punie, H. Wildiers, N. Willers, C. Van Ongeval, G. Van Buggenhout, E. Legius
Risk-reducing mastectomy in BRCA mutation carriers: survival is one of the issues—author's reply
Bernadette Anna Maria Heemskerk-Gerritsen, Maartje Joanneke Hooning